Choline: safety and high intake

Risks of high total choline intake and observational evidence on α-GPC.

Key points

  • High total choline intake may cause fishy body odor, vomiting, sweating, low blood pressure and liver damage. Consider choline from food and all supplements together. [1] See the evidence 1
  • In a Korean observational cohort of people aged 50 and older, α-GPC prescriptions were associated with a higher incidence of stroke; causation was not established. When discussing α-GPC with a professional, consider that the finding relates to this form and observation, not automatically to all choline. [2] See the evidence 1

Practical guide

Check the conclusions and whether they apply to your situation.

Evidence on high choline intake and specific derivatives is considered separately.

Key points

Why these conclusions

What is known about risks

In a Korean insurance cohort of people aged 50 and older, α-GPC prescriptions were associated with a higher incidence of stroke: matched HR 1.43 (95% CI 1.41–1.46). An observational study does not prove causation and does not automatically apply to other forms of choline. [2]

Bitartrate, chloride, phosphatidylcholine, α-GPC and citicoline are different compounds; the mass of the salt is not the mass of choline. The US UL for adults aged 19 and older is 3500 mg total choline per day from food and supplements; high intake is associated with fishy odor, vomiting, sweating, low blood pressure and liver damage. [1]

NIH ODS reports no known clinically significant interactions of choline; this does not establish absence of interactions for all derivatives and combinations. [1]

In the United States, the tolerable upper intake level for total choline for adults aged 19 and older is 3500 mg/day from food and supplements; it is not the dose of one supplement. High total intake can cause fishy body odor, vomiting, sweating, low blood pressure and liver damage. [1]

NIH ODS lists no established clinically significant drug interactions of choline itself; the safety of specific derivatives is assessed separately. [1]

In a Korean insurance cohort of people aged 50 and older, α-GPC prescriptions were associated with a higher incidence of stroke: matched HR 1.43 (95% CI 1.41–1.46). An observational study does not prove causation and does not automatically apply to other forms of choline.

ParameterData
ResultIn a Korean insurance cohort of people aged 50 and older, α-GPC prescriptions were associated with a higher incidence of stroke: matched HR 1.43 (95% CI 1.41–1.46). An observational study does not prove causation and does not automatically apply to other forms of choline.
ParticipantsKorean insurance cohort, age ≥50 years
Formα-GPC prescriptions, dose not randomized
Doseα-GPC prescriptions, dose not randomized
Dose basisα-GPC prescriptions, dose not randomized
ComparatorPeople without α-GPC prescriptions, matched on covariates
Duration10 years
Confidence1/4: Residual confounding, particularly indications for prescribing.; No comparable independent series for this outcome and comparison.; The comparison directly addresses the stated PICO.; Sample size and interval are sufficient to estimate the observed association.; No data for a separate downgrade.
Evidence base1 observational cohort
Sources[2]

Bitartrate, chloride, phosphatidylcholine, α-GPC and citicoline are different compounds; the mass of the salt is not the mass of choline. The US UL for adults aged 19 and older is 3500 mg total choline per day from food and supplements; high intake is associated with fishy odor, vomiting, sweating, low blood pressure and liver damage.

Bitartrate, chloride, phosphatidylcholine, α-GPC and citicoline are different compounds; the mass of the salt is not the mass of choline. The US UL for adults aged 19 and older is 3500 mg total choline per day from food and supplements; high intake is associated with fishy odor, vomiting, sweating, low blood pressure and liver damage. [1]

NIH ODS reports no known clinically significant interactions of choline; this does not establish absence of interactions for all derivatives and combinations.

NIH ODS reports no known clinically significant interactions of choline; this does not establish absence of interactions for all derivatives and combinations. [1]

In the United States, the tolerable upper intake level for total choline for adults aged 19 and older is 3500 mg/day from food and supplements; it is not the dose of one supplement. High total intake can cause fishy body odor, vomiting, sweating, low blood pressure and liver damage.

In the United States, the tolerable upper intake level for total choline for adults aged 19 and older is 3500 mg/day from food and supplements; it is not the dose of one supplement. High total intake can cause fishy body odor, vomiting, sweating, low blood pressure and liver damage. [1]

NIH ODS lists no established clinically significant drug interactions of choline itself; the safety of specific derivatives is assessed separately.

NIH ODS lists no established clinically significant drug interactions of choline itself; the safety of specific derivatives is assessed separately. [1]

More details

How to assess intake

The US upper intake level for adults concerns total choline from food and supplements, not one supplement. [1]

Sources

  1. NIH ODS Choline Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Choline-HealthProfessional/
  2. Association of L-α Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years. https://pmc.ncbi.nlm.nih.gov/articles/PMC8613599/

Methodology: Subpages evidence-led supplement pipeline v1

Ingredient overview: Choline